Norris Medicines Limited (BOM:524414)
India · Delayed Price · Currency is INR 13.96
-0.29 (-2.04%)
At close: Feb 12, 2026
Norris Medicines Market Cap
Norris Medicines has a market cap or net worth of 143.61 million as of February 13, 2026. Its market cap has decreased by -41.74% in one year.
Market Cap
143.61M
Enterprise Value
357.68M
Revenue
72.84M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.96
Market Cap Chart
Since December 3, 2001, Norris Medicines's market cap has increased from 34.30M to 143.61M, an increase of 318.69%. That is a compound annual growth rate of 6.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 139.61M | -12.48% |
| Dec 31, 2025 | 159.51M | -8.07% |
| Dec 31, 2024 | 173.51M | 27.48% |
| Dec 29, 2023 | 136.11M | -1.95% |
| Dec 30, 2022 | 138.81M | 29.72% |
| Dec 31, 2021 | 107.01M | 72.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zenith Healthcare | 180.56M |
| Desh Rakshak Aushdhalaya | 161.38M |
| Sunrest Lifescience | 157.92M |
| Hamps Bio | 149.85M |
| Emmessar Biotech & Nutrition | 138.89M |
| Colinz Laboratories | 137.19M |
| Rekvina Laboratories | 129.36M |
| Cian Healthcare | 125.23M |